Small Wonder

Lab-on-a-Chip For microfluidics, tiny sample volumes move through microchannels etched into a glass chip. Some may argue that the September 1999 release of the Agilent 2100 Bioanalyzer was premature--the technology clearly belongs in the new millennium. With this instrument, Agilent Technologies of Palo Alto, Calif., a Hewlett-Packard subsidiary, in collaboration with Caliper Technologies Corp., of Mountain View, Calif., has achieved the first commercial realization of lab-on-a-chip technology.

Written byBob Sinclair
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Lab-on-a-Chip


For microfluidics, tiny sample volumes move through microchannels etched into a glass chip.
Some may argue that the September 1999 release of the Agilent 2100 Bioanalyzer was premature--the technology clearly belongs in the new millennium. With this instrument, Agilent Technologies of Palo Alto, Calif., a Hewlett-Packard subsidiary, in collaboration with Caliper Technologies Corp., of Mountain View, Calif., has achieved the first commercial realization of lab-on-a-chip technology. The Agilent 2100 performs integrated DNA and RNA analysis on disposable glass chips.

Lab-on-a-chip technologies (not to be confused with array technologies, which are often called DNA chips) have received considerable research attention in recent years. Academic labs, smaller companies (Aclara and CuraGen), and biotech powerhouses (PE Biosystems and SmithKline Beecham) have joined the fray. Much of the excitement stems from pioneering work by Michael Ramsey and coworkers at Oak Ridge National Laboratory in Tennessee. Using the computer industry as a guide for ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies